Profile for Austria Patent: E475412
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Austria Patent: E475412
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 7,645,459 | Jan 9, 2028 | Apil | ATELVIA | risedronate sodium |
| 7,645,460 | Jan 9, 2028 | Apil | ATELVIA | risedronate sodium |
| 8,246,989 | Jan 16, 2026 | Apil | ATELVIA | risedronate sodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
